Search clinical trials for: celecoxib, NPC, gefitinib
Total 387 results
-
Fujian Cancer HospitalUnknown
-
Nurex S.r.l.Purdue University; Università degli Studi di Sassari; Vinmec Healthcare SystemUnknownPlasmodium Falciparum Malaria (Drug Resistant)Vietnam
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Shenzhen People's HospitalUnknown
-
Second Affiliated Hospital of Nanchang UniversityUnknownNon-squamous Non-small Cell Lung Cancer
-
National Taiwan University HospitalCompletedNon-small Cell Lung Cancer (NSCLC)Taiwan
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Daping Hospital and the Research Institute of Surgery...CompletedNSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLCChina
-
Dartmouth-Hitchcock Medical CenterM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; AstraZeneca; Kentuckiana...CompletedNonresectable Adrenocortical CarcinomaUnited States
-
Shanghai Jiao Tong University School of MedicineRenJi Hospital; Huashan Hospital; Ruijin Hospital; Eastern Hepatobiliary Surgery... and other collaboratorsUnknownGallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile DuctChina
-
Sun Yat-sen UniversityUnknown
-
Fujian Cancer HospitalUnknownLung Adenocarcinoma | EGFR MutationChina
-
Centro de Investigação em Saúde de ManhiçaBarcelona Institute for Global HealthCompleted
-
Kanazawa UniversityUnknownNon-Small-Cell Lung CarcinomaJapan
-
David M. Jackman, MDMassachusetts General Hospital; AstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.UnknownNeoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-Small-Cell LungChina
-
Lunxu LiuTerminated
-
Sichuan UniversityAstraZenecaTerminatedNon-small Cell Lung Cancer Metastatic | EGFR Activating MutationChina
-
M.D. Anderson Cancer CenterAstraZenecaCompleted
-
Fujian Cancer HospitalUnknownChemotherapy Effect | NSCLC Stage IVChina
-
Sun Yat-sen UniversityUnknownNon-Small Cell Lung CancerChina
-
Jiangsu Famous Medical Technology Co., Ltd.UnknownNon-small Cell Lung Cancer
-
National Cancer Center, KoreaCompletedLung CancerKorea, Republic of
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer Institute; AstraZeneca; Brigham...CompletedHead and Neck CancerUnited States
-
University College, LondonAstraZenecaTerminatedGlioblastomaUnited Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Qilu Hospital of Shandong UniversityCompletedOveral Survival, Non-small Cell Lung Cancer
-
Rabin Medical CenterCompleted
-
Anhui Medical UniversityUnknownSelf Efficacy | Drug ToxicityChina
-
St. Jude Children's Research HospitalAstraZeneca; National Institutes of Health (NIH)CompletedSolid TumorsUnited States
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
China Medical University, ChinaGeneral Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaboratorsUnknownNon Small Cell Lung Cancer
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungAustria, Germany, Spain, China, Taiwan, Argentina, Australia, Belgium, Brazil, Finland, France, Hungary, India, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Russian Federation, Ukraine, United Kingdom
-
California Cancer ConsortiumNational Cancer Institute (NCI)TerminatedKidney CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University Health Network, TorontoAstraZenecaCompleted
-
Instituto Nacional de Cancerologia de MexicoUnknownEGFR Gene Mutation | Tyrosine Kinase Mutation | Non-Small Cell AdenocarcinomaMexico
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
Chinese Society of Lung CancerGuangdong Provincial People's HospitalCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Peking University Cancer Hospital & InstituteUnknown
-
Hunan Kelun Pharmaceutical Co., Ltd.Completed
-
Hunan Kelun Pharmaceutical Co., Ltd.CompletedBioequivalence Study
-
Peking University Third HospitalUnknownNonsmall Cell Lung CancerChina
-
Guangdong Association of Clinical TrialsChanghai Hospital; First People's Hospital of Hangzhou; Fudan University; Henan... and other collaboratorsCompletedNon-small Cell Lung CancerChina
-
AstraZenecaCompletedCaucasian Patients With EGFR Mutation Positive Advanced NSCLCBulgaria, Italy, Poland, Spain, Turkey, United Kingdom, Romania, Norway, Hungary, Portugal, Greece, Switzerland, France
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownNonsmall Cell Lung Cancer | EGFR Gene Mutation